Acceleron Pharma Email Formats
Contact top employees from
Acceleron Pharma
- Acceleron Pharma uses 6 different email formats. The most common is lastNameInitial-firstNameInitial (for example, d-j@merck.com), which appears in about 57% of work addresses.
- Other common patterns include:
- lastNameInitial-firstName: d-jane@merck.com (12%)
- lastNamefirstName: doejane@merck.com (26%)
Acceleron Pharma’s Popular Email Formats
| Format | Example | Percentage |
|---|---|---|
Format lastNameInitial-firstNameInitial |  d-j@merck.com | Percentage: 57% |
Format lastNamefirstName | doejane@merck.com | Percentage: 26% |
Format lastNameInitial-firstName | d-jane@merck.com | Percentage: 12% |
Format lastName_firstName | doe_jane@merck.com | Percentage: 3% |
Format lastName-firstName | doe-jane@merck.com | Percentage: 1% |
Format firstName.lastNameInitial | jane.d@merck.com | Percentage: 1% |
Contact top employees from
Acceleron Pharma
Ravi KumarSenior Vice President and Chief Scientific Officer
Louis LiuGroup leader/Protein Formulations
Kristen PappasContractor, Clinical Trial Manager
Kevin McLaughlinSenior Vice President and Chief Financial Officer
Lisa SpiessVice President Global Strategic Marketing
Steve ErtelChief Operating Officer
Lee WilsonManager, Cell Culture
Patricia GaniVice President, Human Resources
Crystal FergusonManager, Sales Coordination and Planning, Market Development
Makda TilahunSr. Manager, Clinical Data Management at Acceleron Pharma
Sreeja Reddy PasnoorClinical Data Manager
susmithaSenior Clinical Data Manager
RosalieNational Account Director
KathySystem Support Specialist
Kaity PosadaDirector Regulatory Affairs
Ken LovedaySr. Director, Preclinical Safety Evaluation
0% completed
Verify Acceleron Pharma Business Emails
Acceleron Pharma employee email verification for instant deliverability checks.Companies Similar to Acceleron Pharma
Acceleron Pharma Corporate Information: FAQ
Acceleron Pharma, founded in 2003 and headquartered in Cambridge, MA, operates within the biotech sector. The company focuses on developing biopharmaceuticals for orphan disease therapeutics, rare diseases, and other serious conditions. With a team of 200‑500 employees, Acceleron has generated revenue between $100 million and $500 million and remains an independent entity serving the Greater Boston DMA.
Acceleron’s leadership includes Ravi Kumar as Senior Vice President and Chief Scientific Officer, Kevin McLaughlin as Senior Vice President and CFO, Lisa Spiess heading global strategic marketing, and other senior managers overseeing regulatory affairs, preclinical safety evaluation, clinical data management, protein formulations, sales coordination, human resources, and account management. The organization is classified under SIC code 2836 and operates with a robust internal team that drives its research, development, and market expansion efforts.
Acceleron’s leadership includes Ravi Kumar as Senior Vice President and Chief Scientific Officer, Kevin McLaughlin as Senior Vice President and CFO, Lisa Spiess heading global strategic marketing, and other senior managers overseeing regulatory affairs, preclinical safety evaluation, clinical data management, protein formulations, sales coordination, human resources, and account management. The organization is classified under SIC code 2836 and operates with a robust internal team that drives its research, development, and market expansion efforts.
Acceleron Pharma uses 6 email formats across its organization. The most common pattern is lastNameInitial-firstNameInitial (e.g., d-j@merck.com), used in approximately 57% of work addresses.
Acceleron Pharma currently employs over 200-500 people from United States, Canada, with a head office in Cambridge, MA.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
